Palladini, G., Kastritis, E., Maurer, M. S., Zonder, J., Minnema, M. C., Wechalekar, A. D., . . . Comenzo, R. L. (2020). Daratumumab plus CyBorD for patients with newly diagnosed AL amyloidosis: Safety run-in results of ANDROMEDA. Blood.
Chicago ZitierstilPalladini, Giovanni, et al. "Daratumumab Plus CyBorD for Patients With Newly Diagnosed AL Amyloidosis: Safety Run-in Results of ANDROMEDA." Blood 2020.
MLA ZitierstilPalladini, Giovanni, et al. "Daratumumab Plus CyBorD for Patients With Newly Diagnosed AL Amyloidosis: Safety Run-in Results of ANDROMEDA." Blood 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.